Konstantinos Roditis

Dr. Konstantinos Roditis

Department of Vascular Surgery, Red Cross Hospital, Athens, Attikí, Greece
+1
orcid
Vascular Surgeon

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Journal of Surgical Research
Verified
Journal Article
Closed access
KLKonstantinos Louis
Konstantinos Louis
MNMihai G. Netea
Mihai G. Netea
DCDionyssia-Pinelopi Carrer
Dionyssia-Pinelopi Carrer
AKAntigone Kotsaki
Antigone Kotsaki
VMVassiliki Mylona
Vassiliki Mylona
EGEvangelos J Giamarellos-Bourboulis
Evangelos J Giamarellos-Bourboulis

16 June 2019 in Anaesthesiology Intensive Therapy
Verified
Journal Article
Open access
AAAikaterini N. Alexandropoulou
Aikaterini N. Alexandropoulou
KLKonstantinos Louis
Konstantinos Louis
APAlexandros Papakonstantinou
Alexandros Papakonstantinou
KTKonstantinos Tzirogiannis
Konstantinos Tzirogiannis
ESElissavet Stamataki
Elissavet Stamataki
Konstantinos RoditisKonstantinos Roditis
Konstantinos Roditis
Background: The effect of biphasic positive airway pressure (BPAP) at individualized pressures on the postoperative pulmonary recovery of morbidly obese patients (MOP) undergoing open bariatric surgery (OBS) and possible placebo device-related effects (sham BPAP) were investigated.Methods: Forty-eight MOP scheduled for OBS were initially enrolled. Subjects were randomly assigned to: A) the BPAP group in which BPAP, at individualized inspiratory positive airway pressure/expiratory positive airway pressure (IPAP/EPAP), was applied for 3 days postoperatively and B) the sham BPAP group in which sham BPAP was applied for the same time. Pulmonary function was assessed by spirometry 24 h prior to surgery and at 24, 48 and 72 h postoperatively and respiratory complications were recorded.Results: Thirty-five subjects, 21 in the BPAP group and 14 in the sham BPAP group, completed the study. Baseline characteristics and pulmonary function were similar between groups preoperatively. Subjects in the BPAP group showed in general better spirometric performance and SpO2 values postoperatively and expedited pulmonary recovery. Atelectasis combined with respiratory distress syndrome (RDS) symptoms was observed in 21% of subjects in the sham BPAP group and one of these subjects developed lower respiratory tract infection. No respiratory complications were recorded in the BPAP group. Use of higher BPAP pressures was not associated with anastomosis leakage or disruption in any patient.Conclusion: Use of BPAP, at individualized pressures, expedites postoperative pulmonary recovery and eliminates respiratory complications in MOP who have undergone OBS.

20 October 2022 in EJVES Vascular Forum
Verified
Journal Article
Open access
MRMaria Antonella Ruffino
Maria Antonella Ruffino
SCSharon Chan
Sharon Chan
PCPatrick Coughlin
Patrick Coughlin
AAAyoola Awopetu
Ayoola Awopetu
PSPhilip Stather
Philip Stather
RBRuth A. Benson
Ruth A. Benson
To document the recovery of vascular services in Europe following the first COVID-19 pandemic peak. An online structured vascular service survey with repeated data entry between 23 March and 9 August 2020 was carried out. Unit level data were collected using repeated questionnaires addressing modifications to vascular services during the first peak (March – May 2020, “period 1”), and then again between May and June (“period 2”) and June and July 2020 (“period 3”). The duration of each period was similar. From 2 June, as reductions in cases began to be reported, centres were first asked if they were in a region still affected by rising cases, or if they had passed the peak of the first wave. These centres were asked additional questions about adaptations made to their standard pathways to permit elective surgery to resume. The impact of the pandemic continued to be felt well after countries’ first peak was thought to have passed in 2020. Aneurysm screening had not returned to normal in 21.7% of centres. Carotid surgery was still offered on a case by case basis in 33.8% of centres, and only 52.9% of centres had returned to their normal aneurysm threshold for surgery. Half of centres (49.4%) believed their management of lower limb ischaemia continued to be negatively affected by the pandemic. Reduced operating theatre capacity continued in 45.5% of centres. Twenty per cent of responding centres documented a backlog of at least 20 aortic repairs. At least one negative swab and 14 days of isolation were the most common strategies used for permitting safe elective surgery to recommence. Centres reported a broad return of services approaching pre-pandemic “normal” by July 2020. Many introduced protocols to manage peri-operative COVID-19 risk. Backlogs in cases were reported for all major vascular surgeries.

19 September 2024 in EJVES Vascular Forum
Verified
Journal Article
Open access
PBPanagiota Birmpili
Panagiota Birmpili
RBRuth A. Benson
Ruth A. Benson
BGBrenig Gwilym
Brenig Gwilym
SNSandip Nandhra
Sandip Nandhra
NANina Al-Saadi
Nina Al-Saadi
EZEwa M. Zywicka
Ewa M. Zywicka
The first COVID-19 pandemic wave was a period of reduced surgical activity and redistribution of resources to only those with late stage or critical presentations. This Vascular and Endovascular Research Network COVID-19 Vascular Service (COVER) study aimed to describe the six-month outcomes of patients who underwent open surgery and or endovascular interventions for major vascular conditions during this period. In this international, multicentre, prospective, observational study, centres recruited consecutive patients undergoing vascular procedures over a 12-week period. The study opened in March 2020 and closed to recruitment in August 2020. Patient demographics, procedure details, and post-operative outcomes were collected on a secure online database. The reported outcomes at 30 days and six months were post-operative complications, re-interventions, and all cause in-hospital mortality rate. Multivariable logistic regression was used to assess factors associated with six-month mortality rate. Data were collected on 3 150 vascular procedures, including 1 380 lower limb revascularisations, 609 amputations, 403 aortic, 289 carotid, and 469 other vascular interventions. The median age was 68 years (interquartile range 59, 76), 73.5% were men, and 1.7% had confirmed COVID-19 disease. The cumulative all cause in-hospital, 30-day, and six-month mortality rates were 9.1%, 10.4%, and 12.8%, respectively. The six-month mortality rate was 32.1% (95% CI 24.2–40.8%) in patients with confirmed COVID-19 compared with 12.0% (95% CI 10.8–13.2%) in those without. After adjustment, confirmed COVID-19 was associated with a three times higher odds of six-month death (adjusted OR 3.25, 95% CI 2.18–4.83). Increasing ASA grade (3–5 vs. 1–2), frailty scores 4–9, diabetes mellitus, and urgent and or immediate procedures were also independently associated with increased odds of death by six months, while statin use had a protective effect. During the first wave of the pandemic, the six-month mortality rate after vascular and endovascular procedures was higher compared with historic pre-pandemic studies and associated with COVID-19 disease.

1 April 2011 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
SAStefanos Atmatzidis
Stefanos Atmatzidis
IKIOANNIS KOUTELIDAKIS
IOANNIS KOUTELIDAKIS
GCGrigorios Chatzimavroudis
Grigorios Chatzimavroudis
KLKonstantinos Louis
Konstantinos Louis
APAikaterini Pistiki
Aikaterini Pistiki
EGEvangelos J Giamarellos-Bourboulis
Evangelos J Giamarellos-Bourboulis

7 June 2015 in Case Reports in Surgery
Verified
Journal Article
Open access
PDF file
EMEvangelos P. Misiakos
Evangelos P. Misiakos
GBGeorge Bagias
George Bagias
DTDina Tiniakos
Dina Tiniakos
Konstantinos RoditisKonstantinos Roditis
Konstantinos Roditis
NZNick Zavras
Nick Zavras
AMAnastasios Machairas
Anastasios Machairas
A 71-year-old female patient with cholelithiasis who had undergone laparoscopic cholecystectomy was admitted with obstructive jaundice (total bilirubin ~6mg/dL) three months later. An ERCP was performed, in which a gallstone was found, followed by a sphincterotomy and cleansing of the bile duct. Due to deterioration of jaundice (>25mg/dL), a new, unsuccessful ERCP and stent placement was carried out. Because of ongoing cardiac failure, she underwent an echocardiogram which revealed restrictive cardiomyopathy possibly due to amyloidosis. A liver biopsy was performed, which was positive for amyloid deposits in the liver, and the diagnosis was confirmed by the detection of monoclonal λ IgG protein in urine. The patients jaundice gradually deteriorated and she died one week later from hepatic insufficiency.